Vasamed, Inc. (VSMD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2005 | 22.12 Thousand USD | 352.56% |
| 2004 | -8759.00 USD | 49.43% |
| 2003 | -17.32 Thousand USD | 92.89% |
| 2002 | -243.75 Thousand USD | -129.57% |
| 2001 | 824.43 Thousand USD | -18.46% |
| 2000 | 1.01 Million USD | 221.78% |
| 1999 | -830.27 Thousand USD | 88.63% |
| 1998 | -7.3 Million USD | 55.49% |
| 1997 | -16.4 Million USD | 45.51% |
| 1996 | -30.1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2006 Q1 | -258.71 Thousand USD | -1269.47% |
| 2006 Q3 | 2.38 Million USD | 86.73% |
| 2006 Q2 | 1.27 Million USD | 592.88% |
| 2005 Q2 | -90.11 Thousand USD | 48.75% |
| 2005 Q4 | 22.12 Thousand USD | 102.96% |
| 2005 Q1 | -175.83 Thousand USD | -1907.44% |
| 2005 FY | 22.12 Thousand USD | 352.56% |
| 2005 Q3 | -746.54 Thousand USD | -728.43% |
| 2004 Q4 | -8759.00 USD | -100.26% |
| 2004 FY | -8759.00 USD | 49.43% |
| 2004 Q1 | -25.4 Thousand USD | -46.64% |
| 2004 Q2 | -63.26 Thousand USD | -149.07% |
| 2004 Q3 | 3.34 Million USD | 5385.95% |
| 2003 Q1 | -15.24 Thousand USD | 93.75% |
| 2003 Q2 | -767.39 Thousand USD | -4935.08% |
| 2003 FY | -17.32 Thousand USD | 92.89% |
| 2003 Q4 | -17.32 Thousand USD | 65.3% |
| 2003 Q3 | -49.91 Thousand USD | 93.5% |
| 2002 FY | -243.75 Thousand USD | -129.57% |
| 2002 Q4 | -243.75 Thousand USD | -418.7% |
| 2002 Q3 | -46.99 Thousand USD | 22.91% |
| 2002 Q2 | -60.95 Thousand USD | -104.19% |
| 2002 Q1 | 1.45 Million USD | 76.28% |
| 2001 Q3 | 2.8 Million USD | 23.92% |
| 2001 Q4 | 824.43 Thousand USD | -70.57% |
| 2001 FY | 824.43 Thousand USD | -18.46% |
| 2001 Q1 | 1.59 Million USD | 57.39% |
| 2001 Q2 | 2.26 Million USD | 42.07% |
| 2000 FY | 1.01 Million USD | 221.78% |
| 2000 Q2 | 1.18 Million USD | 894.9% |
| 2000 Q4 | 1.01 Million USD | -24.97% |
| 2000 Q3 | 1.34 Million USD | 13.29% |
| 2000 Q1 | 119.56 Thousand USD | 114.4% |
| 1999 Q1 | -4.6 Million USD | 36.99% |
| 1999 Q2 | -3 Million USD | 34.78% |
| 1999 Q3 | -1.8 Million USD | 40.0% |
| 1999 Q4 | -830.27 Thousand USD | 53.87% |
| 1999 FY | -830.27 Thousand USD | 88.63% |
| 1998 Q3 | -10 Million USD | 20.63% |
| 1998 Q2 | -12.6 Million USD | 19.75% |
| 1998 Q1 | -15.7 Million USD | 4.27% |
| 1998 FY | -7.3 Million USD | 55.49% |
| 1998 Q4 | -7.3 Million USD | 27.0% |
| 1997 FY | -16.4 Million USD | 45.51% |
| 1997 Q3 | -19.3 Million USD | 16.81% |
| 1997 Q2 | -23.2 Million USD | 11.79% |
| 1997 Q4 | -16.4 Million USD | 15.03% |
| 1997 Q1 | -26.3 Million USD | 12.62% |
| 1996 Q4 | -30.1 Million USD | 8.51% |
| 1996 Q1 | -37.8 Million USD | 0.0% |
| 1996 FY | -30.1 Million USD | 0.0% |
| 1996 Q3 | -32.9 Million USD | 6.27% |
| 1996 Q2 | -35.1 Million USD | 7.14% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 95.388% |
| Ansell Limited | -54.99 Million USD | 100.04% |
| Ansell Limited | -55.1 Million USD | 100.04% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 100.061% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 121.048% |
| Psykey, Inc. | 634.59 Thousand USD | 96.514% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.998% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.998% |
| Encision Inc. | 1.29 Million USD | 98.286% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 99.042% |
| Innovative MedTech Inc. | 1.76 Million USD | 98.746% |
| LifePoint, Inc. | -3.26 Million USD | 100.678% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 99.549% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 98.977% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 151.085% |
| Reflect Scientific, Inc. | -1.03 Million USD | 102.137% |
| SmileDirectClub, Inc. | 778.67 Million USD | 99.997% |
| Sector 10, Inc. | 163 Thousand USD | 86.428% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.005% |
| SheerVision, Inc. | 57.34 Thousand USD | 61.426% |
| United Health Products, Inc. | 660.56 Thousand USD | 96.651% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 99.159% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 97.135% |